Kato S - Search Results

1

Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.

Kato S, Shields PG, Caporaso NE, Sugimura H, Trivers GE, Tucker MA, Trump BF, Weston A, Harris CC. Kato S, et al. Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):515-8. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8000304

2

Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.

Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, Weston A, Harris CC. Kato S, et al. Cancer Res. 1992 Dec 1;52(23):6712-5. Cancer Res. 1992. PMID: 1423319

3

Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.

Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG. Kato S, et al. J Natl Cancer Inst. 1995 Jun 21;87(12):902-7. doi: 10.1093/jnci/87.12.902. J Natl Cancer Inst. 1995. PMID: 7666479

4

Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.

Kato S, Onda M, Matsukura N, Tokunaga A, Matsuda N, Yamashita K, Shields PG. Kato S, et al. Cancer. 1996 Apr 15;77(8 Suppl):1654-61. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1654::AID-CNCR35>3.0.CO;2-X. Cancer. 1996. PMID: 8608558

5

Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease.

Kato S, Onda M, Matsukura N, Tokunaga A, Tajiri T, Kim DY, Tsuruta H, Matsuda N, Yamashita K, Shields PG. Kato S, et al. Pharmacogenetics. 1995;5 Spec No:S141-4. doi: 10.1097/00008571-199512001-00016. Pharmacogenetics. 1995. PMID: 7581484

6

7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay.

Kato S, Petruzzelli S, Bowman ED, Turteltaub KW, Blomeke B, Weston A, Shields PG. Kato S, et al. Carcinogenesis. 1993 Apr;14(4):545-50. doi: 10.1093/carcin/14.4.545. Carcinogenesis. 1993. PMID: 8386066

7

Distribution of 7-alkyl-2'-deoxyguanosine adduct levels in human lung.

Blömeke B, Greenblatt MJ, Doan VD, Bowman ED, Murphy SE, Chen CC, Kato S, Shields PG. Blömeke B, et al. Among authors: kato s. Carcinogenesis. 1996 Apr;17(4):741-8. doi: 10.1093/carcin/17.4.741. Carcinogenesis. 1996. PMID: 8625485

8

Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.

Shields PG, Kato S, Bowman ED, Petruzzelli S, Cooper DP, Povey AC, Weston A. Shields PG, et al. Among authors: kato s. IARC Sci Publ. 1993;(124):243-54. IARC Sci Publ. 1993. PMID: 8225491

9

Molecular epidemiology of lung and breast cancer.

Ambrosone CB, Kato S, Bowman ED, Harrington AM, Blomeke B, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Shields PG. Ambrosone CB, et al. Among authors: kato s. Eur J Cancer Prev. 1996 Oct;5(5):391-2. Eur J Cancer Prev. 1996. PMID: 8972270 Review. No abstract available.

10

Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism.

Kato S, Tajiri T, Matsukura N, Matsuda N, Taniai N, Mamada H, Yoshida H, Kiyam T, Naito Z. Kato S, et al. Scand J Gastroenterol. 2003 Aug;38(8):886-93. doi: 10.1080/00365520310004489. Scand J Gastroenterol. 2003. PMID: 12940444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,121 results

Search Page

Filters